Crossmark

SARS-CoV-2 vaccination and metabolic radionuclide therapy: Document of the SEMNIM Endocrinology Working Group

Crossref DOI link: https://doi.org/10.1016/j.remnie.2021.07.001

Published Print: 2021-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Negre Busó, Montserrat

Rodríguez Gasen, Alba

Torrent Llongarriu, Èlia

Estorch Cabrera, Montserrat
License Information

Text and Data Mining valid from 2021-09-01
More Information

This article is maintained by: Elsevier

Article Title: SARS-CoV-2 vaccination and metabolic radionuclide therapy: Document of the SEMNIM Endocrinology Working Group

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2021.07.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2021.07.001

Content Type: simple-article

Copyright: © 2021 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.